Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
ter Haar, E., Harrison, S
J Pharmacol Exp Ther 282(3):15331540 Thompson RA, Isin EM, Li Y, Weidolf L, Page K, Wilson I, Swallow S, Middleton B, Stahl S, Foster AJ, Dolgos H, Weaver R, Kenna JG (2012) In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs
These drugs are being prescribed to assist patients with losing weight
Development of New Formulations : Scientists are exploring new formulations of GLP-1 agonists to optimize their delivery and improve patient adherence to treatment regimens
US$ 28.77
US$ 29.43
US$ 21.40
